Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis
- PMID: 8311558
- PMCID: PMC1005245
- DOI: 10.1136/ard.53.1.58
Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis
Abstract
Objectives: The evaluation of the role of polymorphism within the class II encoded antigen processing genes, LMP2 and TAP, in susceptibility to ankylosing spondylitis (AS).
Methods: Eighty five patients with ankylosing spondylitis, 35 B27 positive healthy controls, and 55 unrelated healthy controls were studied. TAP1 and TAP2 alleles were assigned by ARMS PCR, and LMP2 alleles were assigned by restriction enzyme digestion of a PCR product.
Results: The TAP1C allele was increased in the AS group (6%) compared with random controls (1%), p = 0.03 and TAP2E was increased in AS (3.5%) compared with random controls (0%), p = 0.05. However, the frequencies of these alleles were also increased in B27 matched controls. There were no differences in LMP2 allele or genotype frequencies between AS and either of the control groups. Partitioning of patients according to presence or absence of uveitis did not reveal any significant associations.
Conclusions: Increases of the minor TAP alleles, 1C and 2E, in AS reflect linkage disequilibrium between these alleles and HLA-B27. Polymorphism of the class I antigen processing pathway does not contribute significantly to AS susceptibility nor to the development of anterior uveitis associated with AS.
Similar articles
-
TAP polymorphism is not associated with ankylosing spondylitis and complications with acute anterior uveitis in HLA-B27-positive Japanese.Tissue Antigens. 1998 Nov;52(5):478-83. doi: 10.1111/j.1399-0039.1998.tb03075.x. Tissue Antigens. 1998. PMID: 9864038
-
Major histocompatibility complex-encoded antigen processing gene polymorphism in IDDM.Diabetes. 1994 Jan;43(1):110-7. doi: 10.2337/diab.43.1.110. Diabetes. 1994. PMID: 7903260
-
TAP1 and TAP2 polymorphism in HLA-B27-positive subpopulations: no allelic differences in ankylosing spondylitis and reactive arthritis.Hum Immunol. 1995 Dec;44(4):236-42. doi: 10.1016/0198-8859(95)00116-6. Hum Immunol. 1995. PMID: 8770637
-
Genetic susceptibility to ankylosing spondylitis.Curr Mol Med. 2004 Feb;4(1):13-20. doi: 10.2174/1566524043479284. Curr Mol Med. 2004. PMID: 15011955 Review.
-
Polymorphism of HLA-B27: 105 subtypes currently known.Curr Rheumatol Rep. 2013 Oct;15(10):362. doi: 10.1007/s11926-013-0362-y. Curr Rheumatol Rep. 2013. PMID: 23990399 Review.
Cited by
-
Polymorphism of the LMP2 gene and disease phenotype in ankylosing spondylitis: no association with disease severity.Clin Rheumatol. 1997 Sep;16(5):461-5. doi: 10.1007/BF02238938. Clin Rheumatol. 1997. PMID: 9348140 Clinical Trial.
-
Genetic association between TAP1 and TAP2 polymorphisms and ankylosing spondylitis: a systematic review and meta-analysis.Inflamm Res. 2017 Aug;66(8):653-661. doi: 10.1007/s00011-017-1047-1. Epub 2017 Apr 12. Inflamm Res. 2017. PMID: 28405734
-
The LMP2 CfoI polymorphism is associated with ankylosing spondylitis (AS) risk but not with acute anterior uveitis (AAU): A meta-analysis.Medicine (Baltimore). 2019 Nov;98(45):e17804. doi: 10.1097/MD.0000000000017804. Medicine (Baltimore). 2019. PMID: 31702633 Free PMC article.
-
Differentially expressed mRNAs, lncRNAs, and miRNAs with associated co-expression and ceRNA networks in ankylosing spondylitis.Oncotarget. 2017 Nov 27;8(69):113543-113557. doi: 10.18632/oncotarget.22708. eCollection 2017 Dec 26. Oncotarget. 2017. PMID: 29371928 Free PMC article.
-
Quantitative Proteomic Analyses To Reveal the Key Features of Proteins in New Onset Ankylosing Spondylitis Patients.ACS Omega. 2020 Aug 3;5(32):20153-20161. doi: 10.1021/acsomega.0c01776. eCollection 2020 Aug 18. ACS Omega. 2020. PMID: 32832769 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous